Abbott Laboratories (ABT:SELL) Sales falling faster in Q1:14 due to weakness in multiple segments.

Written by Super User on 17 April 2014.

Acme United Corp. (ACU:BUY) The company reported solid first quarter results with revenue ahead of our estimates while EPS missing our projections.

Written by Super User on 27 April 2018.

Angie’s List, Inc. (ANGI:NA) Our SELL thesis as outlined in our August 20, 2013 Initiation report has played out with the stock declining approximately 50% from that date.

Written by Super User on 29 April 2014.

Anika Therapeutics (ANIK:BUY) ANIK shares drop 37% after disappointing results from Cingal 16-02 Phase III clinical trial.

Written by Super User on 22 June 2018.

Anika Therapeutics (ANIK:BUY) Anika Therapeutics Product revenues rise 8% YOY primarily as a result of higher sales of Monovisc.

Written by Super User on 01 August 2018.

Anika Therapeutics (ANIK:BUY) Sales of Monovisc and Cingal drive revenues. Q1:18 top-line negatively impacted by voluntary recall of HYAFF-related products

Written by Super User on 11 May 2018.

Arabian American Dev. Co. (ARSD:BUY) Record Q4 petrochemical revenues (+33%) driven by 40% rise in volumes.

Written by Super User on 24 April 2014.

Arlington Asset Investment (AI:BUY) Dropping coverage to redirect our research resources to cover issuers with better visibility,

Written by Super User on 09 May 2018.

Arotech (ARTX:NA) Dropping coverage based on lack of visibility of future cashflows from an uncertain pipeline in securing contracts.

Written by Super User on 01 August 2018.

Aviat Networks, Inc. (AVNW:BUY) Telecom equipment company expected to return to profitability on strong demand for microwave transmission products in emerging markets.

Written by Super User on 29 April 2014.

Avid Technology (AVID:DROP) We are TERMINATING coverage in order to re-focus resources.

Written by Super User on 22 August 2016.

Banco Latinoamericano (BLX:BUY) Net income in Q1:18 fell far short of our estimate attributable to lower interest earning assets

Written by Super User on 17 May 2018.

Banco Latinoamericano (BLX:BUY) Net income in Q2:18 disappointed again, attributable to weak interest earning assets

Written by Super User on 13 August 2018.

Banco Latinoamericano (BLX:BUY) Net income in Q2:18 fell far short of our estimate attributable to lower interest earning assets

Written by Super User on 23 July 2018.

Banco Latinoamericano (BLX:BUY) Successful reduction in the credit portfolio exposure to Brazil

Written by Super User on 24 August 2016.

Biolase Technology (BIOL:BUY Long Term) Q1:18 sales decline 8% YOY due primarily to lower domestic laser sales.

Written by Super User on 08 May 2018.

Biolase Technology (BIOL:BUY Long-term) Regionally-focused marketing initiative drives nearly 200% YOY growth in Q2:18 laser sales

Written by Super User on 10 August 2018.

Black Hills Corporation (BKH:BUY) Dropping coverage to redirect resources to candidates that have better growth prospects and less street coverage

Written by Super User on 09 May 2018.

Century Casinos, Inc. (CNTY:BUY) Continued execution on a growth strategy based on new gaming venues and expanded capacity appears to be delivering continued growth

Written by Super User on 22 August 2016.

ClearOne (CLRO:Buy Long-Term) Challenges continue to mount as revenues drop 37.6% year-over-year and 21.2% sequentially due to competitor products

Written by Super User on 21 June 2018.

1
2
3
4